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Ergot alkaloid synthetic capacity of Penicillium camemberti 
Samantha Fabian 
 
Penicillium camemberti plays a major role in the ripening process of brie and 
camembert type cheeses.  Investigation of the recently sequenced P. camemberti 
genome revealed the presence of a cluster of five genes previously shown to be 
required for ergot alkaloid synthesis in other fungi.  Clustered with the five ergot alkaloid 
synthesis genes (aka eas genes) were two additional genes with that had the apparent 
capacity to encode enzymes involved in secondary metabolism.  We analyzed samples 
of brie and camembert cheeses as well as cultures of P. camemberti grown under 
different conditions and were not able to detect any known ergot alkaloids, indicating the 
P. camemberti eas genes were either not expressed or encoded non-functional 
enzymes.  We used a heterologous expression strategy to investigate the theoretical 
biosynthetic capacity of P. camemberti.  Based on studies with the related ergot 
alkaloid-producing fungus Neosartorya fumigata (syn. Aspergillus fumigatus), the five 
known eas genes found clustered in the P. camemberti genome should give the fungus 
the capacity to produce the ergot alkaloid chanoclavine-I aldehyde.  We used a 
chanoclavine-I aldehyde-accumulating mutant of N. fumigata as a recipient strain in 
which to express the two uncharacterized P. camemberti eas cluster genes (named 
easH and easQ) to create a functioning facsimile of the P. camemberti cluster.  
Expression of easH and easQ in the chanoclavine-I accumulating N. fumigata resulted 
in the accumulation of a pair of compounds of m/z 269.1 in positive mode LC-MS.  
Since this m/z is consistent with the mass of the isomeric pair of [rugulovasine A/B + H], 
we analyzed a culture of the related rugulovasine producer Penicillium biforme and 
found the same isomeric pair of analytes.  Fragmentation of the analytes yielded 
fragments typical of those resulting from fragmentation of rugulovasine A/B.  The 
deduced activities of the products of easH and easQ catalyze theoretical reactions that 
provide a reasonable pathway from the precursor chanoclavine-I aldehyde to the 
products rugulovasine A/B. When individually studied, the chanoclavine-I aldehyde-
accumulating mutant of N. fumigata transformed with the P. camemberti easQ gene 
yielded a ratio of analytes at m/z 271.1 vs. m/z 255.1 that support the theorized 
mechanisms of easH and easQ to produce rugulovasines.  The P. biforme genome 
contains a homologous eas cluster with only 12 mutations relative to that of P. 
camemberti. Eleven of the 12 mutations were investigated via complementation studies 
of the mutated genes (dmaW, easC, easE) using knockout strains of N. fumigata.  The 
data indicate that P. camemberti has the genes to produce the ergot alkaloid 
rugulovasine A/B but that during domestication isolates that failed to produce alkaloids 
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Introduction/ Literature Review  
P. camemberti history and importance  
Camembert type cheeses were thought to be first made in 1791 in the village of 
Camembert, near Normandy, France by Marie Harel (Spinnler and Gripon, 2004). While 
Camembert is a popular choice for U.S. consumers today, it holds historical significance 
in French culture. The WWI French troops were famously issued the cheese in their 
military rations and thus it gained popularity. The process of this making cheese is 
highly dependent on P. camemberti.  Without the fungus, the cheese would not have 
the characteristic flavor and texture, as the mold plays a crucial part in the ripening 
process.  
During the initial stages of the cheese making process, the milk is inoculated with 
P. camemberti as well as bacterial cultures and renin. As the cheese matures, the 
fungus colonizes the entire outside surface area giving the cheese its characteristic 
white felt rind. Perhaps the biggest contribution P. camemberti has to the ripening 
process is its ability to oxidize lactate, as the lactate is the main food source for the 
fungus (McSweeny, 2004). As a result of the lactate metabolism, gradients are 
established that help with the transport of other compounds from the middle of the 
cheese to the surface rind. P. camemberti oxidizes lactate to CO2 and O2 and over time 
results in increasing the pH of the rind of the cheese (McSweeny, 2004). This 
deacidification leads to the creation of a pH gradient from the cheese center to the rind 
which allows lactate to move to the rind surface, where it is oxidized by P. camemberti. 
The increase in pH on the rind also creates a calcium phosphate gradient, which allows 
migration of calcium and phosphate from the center to the cheese surface.  The 
proteolysis by P. camemberti on the rind creates an excess of ammonia, which diffuses 
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into the cheese giving it its distinct odor. The initial oxidation of the lactate of the cheese 
is key in its production as it continues until all of the available lactate is metabolized.   
The degradation of protein in camembert cheeses is very complex and involves 
many different microorganisms including lactic acid bacteria. However, P. camemberti 
contributes to the proteolysis of the cheese by making aspartyl and metalloproteinases, 
acid carboxypeptidase and an alkaline aminopeptidase (McSweeny, 2004). The aspartyl 
proteinases acts on α-casein, while the acid carboxypeptidases work on β-casein, 
hydrolyzing the Lys97-Va98l, Lys99-Glu100, and Lys29-Ile30 bonds (McSweeney & 
Fox, 2004).  In the process of lipolysis, the milk itself contains lipolytic agents such as 
lipoprotein lipase. The renin coagulant and the starter microorganisms can also provide 
lipases that can metabolize the lipids present. P. camemberti has been found to oxidize 
linoleic and linolenic acids with lipoxygenases and hydroperoxide-lipases. It is capable 
of producing 9-, 10-, and 13-hydroperoxy acids from polyunsaturated fatty acid oxidation 
(Spinnler and Gripon, 2004).  However, there is minimal lipolysis occurring in the 
cheese as the high lipid concentrations give the cheese its creamy texture.  
Gene clusters and secondary metabolites  
Fungi have interesting clusters of genes that encode the ability to produce 
secondary metabolites, or chemical compounds that can be beneficial in some way for 
the fungi. These clusters can code for catabolic pathways, activated to allow the fungus 
to survive under low nutrient/competitive environments by using low molecular weight 
nutrients as energy source (Keller and Hohn, 1997). They also code for enzymes that 
act as catalysts of biosynthetic pathways producing secondary metabolites (Keller and 
Hohn, 1997).  While there are many, some common examples include penicillin and 
ergot alkaloids. The secondary metabolites can be beneficial or sometimes harmful to 
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plants, humans and animals. Secondary metabolite production is controlled by the 
activation/deactivation of the transcription of certain genes that are found in a cluster 
(Brakhage and Schroeckh, 2011). These gene clusters are unique to the chemical 
compound being produced but can be found in an array of different fungi. On another 
note, the discovery of these gene cluster does not mean the fungus is producing the 
metabolite, but rather that it has the potential to produce it.  
Examples of secondary metabolites produced by Penicillium species  
Penicillium species are producers of many secondary metabolites such as the 
well-known antibiotic penicillin. P. camemberti has been known to produce 
acetaldehyde, benzaldehyde, 3-methylbutanal and 1-octen-3-ol to inhibit the bacteria 
Listeria monocytogenes and Salmonella typhimurium (Larsen and Knochel, 1997). It is 
believed that the production of these chemicals is beneficial to P. camemberti as it 
reduces the competition of these potentially pathogenic gram negative/gram positive 
bacteria by inhibiting their growth. Additionally, P. roqueforti the fungus associated with 
the production of blue/roquefort cheese has been known to make antibiotics such as 
penicillin,  as well as mycophenolic acid and patulin (Neilsen et al., 2006). P. roqueforti 
is also known for making ergot alkaloids festuclavine, isofumigaclavine A and 
isofumigaclavine B (Neilsen et al., 2006). Festuclavine is also made by P. crustosum, P. 
palitans and P. oxalicum (Kozlovsky, 1999) Therefore, it is not uncommon for 
Penicillium species to produce ergot alkaloids.  
Ergot alkaloids 
Ergot alkaloids are most famously produced by the fungus Claviceps purpurea 
and also are produced by a large range of other fungi including Epichloë spp. and 
Neosartorya fumigata (Panaccione and Coyle, 2005). They can also be produced by 
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certain Penicillium spp. that were previously discussed (Kozlovsky, 1999). Ergot 
alkaloids can be viewed as beneficial or harmful depending on the dose and context. 
Ergot alkaloid derivatives can be used directly or often are modified to serve as 
pharmaceuticals as well as illegal drugs, such as lysergic acid diethylamide or LSD. The 
most popular legal ergot alkaloid-derived drugs produced are for treating migraines, 
depression, prolactin disorders, gynecological issues, dementia and Parkinson’s 
(Hulvova et at., 2013). The known fungal producers of these alkaloids are grown under 
optimal alkaloid production settings and then the alkaloids are extracted for use. 
However, ergot alkaloids can be harmful if consumed without any chemical modification 
or in uncontrolled doses.  Ergot alkaloid poisoning, or ergotism, can cause a wide range 
of symptoms from hallucinations, gangrene, burning skin, neurological diseases and 
even death. Ergotism can occur in both humans and animals. Today, the incidence of 
ergotism is uncommon due to modern farming practices, but high levels of ergot 
alkaloids can still be found in the grasses of less advanced farming systems. 
Historically, ergotism was a widespread problem that was referred to as St. Anthony’s 
Fire that swept across Europe and the early American colonies. The largest epidemic of 
ergotism occurred in 994 AD in Aquitaine, France where around 40,000 people died as 
a result (VanDongen and DeGroot, 1995). 
Mechanism of action  
The above-mentioned benefits and dangers of ergot alkaloids can be explained 
by the mechanism in which they affect the body. Because they have a similar chemical 
structure to the neurotransmitters dopamine, serotonin and norepinephrine, ergot 
alkaloids interact with the receptors for those neurotransmitters (Tudzynski et al., 2001). 
Figure 1 highlights the similarity among an alkaloid and three neurotransmitters.  
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However, the way the alkaloids interact with the neurotransmitters depend on the 
alkaloids structure and the particular sub-type of receptor. In some cases, ergot 
alkaloids act as agonists, whereas in other cases they are antagonists.  Adding different 
chemical substituents to C-8 of the ergoline ring gives the alkaloid different affinities 
toward the different neuroreceptors (Schardl et al., 2006).  Simple peptide ergot 
alkaloids have a high affinity for adrenergic receptors and thus are responsible for the 
vasoconstrictive effects.  However, the clavines have a high affinity for serotonin 
receptors and therefore responsible for the anti-serotoninergic action. Some ergot 
alkaloids can also have an effect on prolactin release and are therefore manipulated for 
pharmaceutical use for conditions like galactorrhea (Schardl et al., 2006). 
Chemistry of ergot alkaloids 
Chemically, the backbone of the alkaloids consists of 3,4-substituted indole 
derivatives with a tetracyclic ergoline ring structure (Tudzynski et al., 2001).  There are 
three group classes of ergot alkaloids: clavines, lysergic acid amides, and ergopeptines 
based on their level of complexity and additional groups (Panaccione, 2005). The 
alkaloids are synthesized from the amino acid tryptophan and then metabolized into 
various pathway end products via enzymatic reactions. The enzymes are coded for by 
ergot alkaloid synthesis or Eas genes.  
Genes of the ergot alkaloid synthesis cluster  
The publicly available genome of P. camemberti features five ergot alkaloid 
synthesis (eas) genes in its genome: dmaW, easC, easE, easF, and easD. In N. 
fumigata, these genes code for the enzymes that catalyze synthesis of DMAPP and 
tryptophan into chanoclavine-l aldehyde (Figure 2; Figure 3).  More specifically, the 
dmaW gene encodes for the enzyme dimethylallyltryptophan synthase which converts 
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tryptophan and DMAPP to dimethylallyltryptophan or DMAT (Wang et al., 2004; Coyle 
and Panaccione, 2005). The easF gene is responsible for coding for the enzyme 
dimethylallyltryptophan-N-methylase which converts DMAT to N-Me-DMAT (Rigbers 
and Li, 2009). Genes easC and easE code for the enzymes catalase and chanoclavine-
synthase, respectively (Lorenz et al., 2010; Goetz et al., 2011). While the exact 
mechanism is unknown, it is known that they work together to form chanoclavine-I 
(Goetz et al., 2011).  The enzyme chanoclavine-I dehydrogenase coded by the easD 
gene then converts chanoclavine-I to chanoclavine-I aldehyde (Wallwey et al., 2011).  
This gene cluster and production of chanoclavine-I aldehyde from tryptophan and 
DMAT is common to most ergot alkaloid producers such as Claviceps/Epichloë and 
Neosartorya/Penicillium. At this point, the synthesis of the specific ergot alkaloids 
produced by the different species is catalyzed by different enzymes in lineage-specific 
branches.  
Susceptible to evolution adaptability and mutability of Penicillium species 
Multiple lines of evidence have led to the idea that Penicillium species are readily 
susceptible to evolutionary processes. One such example of evolutionally adaptation is 
the concept of horizontal gene transfer between different species of Penicillium.  P. 
camemberti and P. roqueforti are known to undergo these gene transfers frequently with 
each other. While these two species of Penicillium are both primarily grown on dairy 
substrates and are used to produce cheese, phylogenetically they are not closely 
related (Cheeseman et al., 2014). However, they were found to undergo the same 
horizontal gene transfers of two genes that give the fungi fitness and competitive 
advantages in a cheese environment (Cheeseman et al., 2014).  
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Penicillium biforme: A close ancestor  
While P. camemberti is a characteristically white mold found exclusively in 
cheese products, it is a descendent of Penicillium biforme and Penicillium fuscoglaucum 
which are blue/gray type molds (Ropars et al., 2015).  Because of its close relation to P. 
camemberti, P. biforme was also studied as part of this thesis project.  P. biforme 
naturally occurs in cheese substrates but has been found to be a contaminant in other 
dairy-based foods and juices as well.  P. bifome is a known producer of the ergot 
alkaloid rugulovasine (Dorner et al., 1980). Like other known ergot alkaloid producers, 
my preliminary investigation of its publicly available genome indicated it has the first five 
ergot alkaloid synthesis genes along with two additional genes, easH and easQ (Figure 
3). Thus, the ability of P. camemberti to produce ergot alkaloids was studied due to its 
close relation to P. biforme and its importance in the production of camembert cheese.  
Rationale and hypothesis: 
Due to the previously studied activities of the five ergot alkaloid synthesis genes 
found in P. camemberti, the ability of this fungus to produce ergot alkaloids was 
researched. Considering that other Penicillium species are capable of producing 
alkaloids and rapidly evolving, it is reasonable to hypothesize that P. camemberti has 
the capacity to produce ergot alkaloids. With P. biforme phylogenetically being a recent 
ancestor to P. camemberti, it could be that during domestication mutations caused this 
gene cluster to no longer function in P. camemberti.  
Methods 
Characterization of P. camemberti and P. biforme ergot alkaloid gene clusters 
The ergot alkaloid gene cluster in P. camemberti was found by comparing 
individual eas genes from N. fumigata to the NCBI database. Contigs containing P. 
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camemberti and P. biforme eas gene clusters were downloaded and additional genes 
were annotated by BlastX searching individual, contiguous 5-kb fragments. 
HPLC analysis 
Fungi were cultured on malt extract agar (6g malt extract, 1.8 maltose, 6g 
dextrose, 1.2g yeast extract per liter of distilled water) for 7 to 10 days, and samples 
were prepared for HPLC analysis by cutting a 1 cm by 1 cm piece of fungus-colonized 
medium and adding it to 400 μL of HPLC grade methanol.  Samples were rotated end-
over-end (15 rpm) for 35 minutes and centrifuged at 13,000 rpm for 10 minutes.  One 
hundred μL of supernatant was placed into an HPLC sample vial and 20 μL was 
analyzed for ergot alkaloids on reverse phase liquid chromatography using a C18 
column and the protocol outlined in Panaccione et al. (2012). Analytes were monitored 
by fluorescence with excitation at 272 nm and the emission 372 nm. The area under the 
peaks were measured and converted into ng/mL using a standard curve generated from 
prior HPLC data.  
Liquid chromatography mass spectrometry (LC-MS) analysis  
Samples were prepared for LC-MS by using 5 mL of 100% methanol to remove 
all spores and hyphae from the malt extract agar cultures grown for 7-21 days. Two mL 
of the harvested spore suspension was centrifuged at 13,000 rpm for 10 minutes. The 
supernatant was collected and concentrated to 100 μL in a speedvac. Ten μL of the 
extract was then analyzed with a Thermo Fisher LCQ LC-MS according to methods 
described by Ryan et al. (2013) except the gradient program initiated with 86% mobile 
phase A (5 parts acetonitrile + 95 parts 0.1% formic acid) and 14% mobile phase B 
(75% acetonitrile arts acetonitrile + 95 parts 0.1% formic acid) and increased linearly to 
100% mobile phase B over 20 minutes.  Flow was maintained at 100% B for 5 min, 
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before initial conditions were restored.  Flow rate was 200 μL/min.  The peaks in the 
chromatograms of interest were measured using the LC-Qual browser and analyzed for 
the observation of conversion ratios.  
Fungal transformation protocol 
Cultures for preparing protoplasts for transformation were grown as follows.  A 2-
cm x 2-cm sample of fungus–colonized malt extract agar of various strains of N. 
fumigata was used as inoculum to start cultures in 50 mL of malt extract broth.  Cultures 
were incubated overnight at 37°C, 80 rpm.  To prepare protoplasts, the broth was 
replaced with 15 mL 0.7 M NaCl that included 40 mg lysing enzyme (Sigma-Aldrich, St. 
Louis, MO) and 1 g VinoTaste Pro (Gusmer Enterprises Inc., Mountainside, NJ).  The 
enzyme-mycelium mixture was then incubated for 2 hours at 37°C and 80 rpm.  The 
mixture was filtered through a miracloth (EMD Chemicals, Gibbstown, NJ) lined funnel 
in order to separate the protoplasts from the hyphae and other debris.  The protoplasts 
were pelleted by centrifuging for three minutes at 3000 rpm. The supernatant was 
decanted, and then the protoplasts were resuspended with 10 mL 0.7 M NaCl and then 
re-pelleted.  The process was then repeated but with resuspension in 5 mL STC (1 M 
Sorbitol, 0mM Tris pH 7.4, 10m 6M CaCl2). The protoplasts were then resuspended in a 
final volume of STC that allowed for a protoplast concentration of 5x106 protoplasts in 
100 µL STC.  Two volumes of 37.5% PEG 8000 and one volume of PEG amendments 
(1.8 M KCl, 150 mM CaCl2, 150 mM Tris pH = 7.4) were mixed together in order to 
prepare a polyethylene glycol (PEG) solution. A quarter of the final protoplast volume 
was calculated, and then the prepared PEG was added in that amount. Ten μL of 
plasmid DNA or PCR product was added to the 125 μL of the final protoplast mixture, 
which was incubated on ice for 30 minutes. One mL of the PEG solution was added to 
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the cells and then the mixture was incubated at room temperature for 20 minutes. The 
solution was then divided among three Petri dishes and mixed with 15 mL molten 
TM102 media, which corresponds to M102 medium as defined by Rykard et al. (1982) 
but containing 1 M sucrose. After the agar had solidified, 15 mL of molten TM102 mixed 
with 800 µg/mL phleomycin (InvivoGen, San Diego, CA) was added on top of solidified 
layer. The plates were incubated at 37 °C for three days.  
Preparation of gene constructs for fungal transformation 
A typical PCR reaction was comprised of 11 μL distilled/deionized water, 5 μL 5x 
Phsuion HF buffer (100 mM KCl, 20 mM Tris-HCl pH 7.4, 1.5 mM MgCl2; Thermo 
Scientific, Waltham, MA),4 μL 1.25 mM dNTPs, 1.25 μL 0.5 mM forward primer,1.25 μL 
0.5 mM reverse primer, 2 μL of template DNA and 0.5 μL of Phusion high-fidelity 
polymerase (Thermo Scientific).The reactions underwent the same general cycle, with 
an initial denaturation at 98°C for 30s, followed by 35 cycles of 98°C (15 s), annealing 
temperature (as defined by primer pair in Table 1) (15 s), and 72°C for and extension 
time as defined in Table 1, followed by a final extension at 72°C for 60 s.  The primers, 
annealing temperatures, and extension times are included in Table 1. The PCR 
products were cleaned using the Zymogen DNA Clean & Concentrator kit (Zymo 
Research Corp., Irvine, CA). The cleaned products observed via gel electrophoresis in 
0.8% agarose.  
Plasmid preparation  
Various restriction enzyme sites were included in the primers used to PCR 
amplify different gene fragments. The PCR products with restriction enzyme sites were 
cleaned using the Zymogen DNA Clean & Concentrator kit (Zymo Research Corp., 
Irvine, CA) and then digested with the appropriate restriction endonuclease for 90 
minutes at 37°C. The following solution mix was used for all digestions: 6 μL of cleaned 
11 
 
PCR products with restriction sites, 10 μL distilled water, 2 μL of CutSmart buffer (New 
England BioLabs, Ipswich, MA) and 1 μL each of the corresponding restriction enzymes 
associated with the specific gene products. A previously prepared pBCPhleo PCR 
product was also digested under the same conditions with the same set of restriction 
enzymes used for the individual gene PCR product. The digested products were 
cleaned using the Zymogen DNA Clean & Concentrator kit. The cleaned digests were 
loaded on a 0.8% agarose gel and the intensities of the products were recorded. A 
ligation reaction was created based on the observed intensities of the digested 
fragments, with 8 μL of the mixture being comprised of a ratio of the amplified gene 
digest and the digested pBCphleo; along with 1 μL of 10x ligation buffer and 1 μL of 
ligase (New England BioLabs, Ipswich, MA). The solution was incubated at 16°C 
overnight. The ligation was then transformed into a Novagen NovaBlue™ Competent E 
.coli cells (EMD Biosciences Inc,  Darmstadt, Germany) and grown on LB + 
chloramphenicol (50 μg/mL) agar. Resulting colonies were isolated and grown in 2 mL 
of LB + chloramphenicol broth and incubated at 37°C overnight. The cells were pelleted 
and the plasmids were purified using the Zyppy™ Plasmid Miniprep kit (Zymo Research 
Corp., Irvine, CA).  
Expression of of easQ/easH Fusion PCR product in N. fumigata 
The easH and easQ genes of P. camemberti were individually PCR amplified 
using primer sets 13 and 14 (Table 1). The cleaned PCR products were then then 
attached to a N. fumigata easA/easG bidirectional promoter via fusion PCR. The 
previously generated easH, easQ and a previously generated N. fumigata promoter 
PCR products were used as template DNA and the primer set 15 (Table 1). The 4145-
bp fusion PCR product along with a previously created pBCphleo linear plasmid were 
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co-transformed in an equal molar concentration into a previously created chanoclavine-l 
aldehyde accumulating easA ko strain of N. fumigata (Coyle et al., 2010).  
Transformants were analyzed by HPLC with fluorescence detection and LC-MS. 
Observation of the individual function of P. camemberti easH and easQ  
P. camemberti easH and easQ gene fragments with restriction enzyme sites 
were PCR amplified using primers 11 and 12, respectively (Table 1).  The easH 
fragment contained restriction enzyme sites for NotI and BamHI, while the easQ PCR 
product contained sites for NotI and SpeI. The PCR products were digested with their 
corresponding restriction enzyme set, cleaned, and then ligated with pBCphleo. The 
resulting plasmid was used for fungal transformation into the N. fumigata easA knockout 
strain (Coyle et al., 2010). The successful transformants were analyzed by HPLC with 
fluorescence detection along with LC-MS.  
Functional analysis of P. camemberti easC, easE and dmaW 
The functionality of P. camemberti easC, easE and dmaW was tested by using 
those genes in attempted complementation of previously characterized N. fumigata 
knockout mutants.  The P. camemberti gene fragments were PCR amplified using 
primer sets 1, 2 and 3 (Table 1) that included restriction enzyme sites.  The easC 
fragment contained sites for BamHI and EcoRI, easE featured sites for NotI and SpeI, 
and dmaW had restriction enzyme sites for NotI and BamHI. The cleaned PCR products 
were digested with the indicated restriction enzyme set, cleaned and then ligated with 
similarly-digested pBCphleo. The resulting plasmids were used for fungal transformation 
into previously made easC, easE and dmaW knockout strains of N. fumigata (Goetz et 
al., 2011; Coyle & Panaccione, 2005). The transformants were plated on malt extract 
agar plates and analyzed by HPLC with fluorescent detection.  
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Extraction of messenger RNA and preparation of cDNA 
Cultures of P. camemberti NRRL 874 were grown as surface cultures on malt 
extract broth for three days at room temperature. A 100 mg sample of the fungal mat 
was then frozen with liquid nitrogen and ground into a powder with a mortar and pestle. 
RNA was then extracted by following the instructions of the Qiagen RNeasy Plant kit 
(Qiagen Company, Hilden, Germany). cDNA was obtained by reverse transcribing the 
mRNA with SuperScript IV reverse transcriptase (Thermo Scientific, Waltham, MA). The 
cDNA was then used as template for primer sets 4, 5, 6, 7, 8, 9 and 10 (Table 1). PCR 
products were analyzed via gel electrophoresis.  
Analysis of different Penicillium spp. isolates and cheese prepared with P. 
camemberti or P. biforme for ergot alkaloids 
Cultures of P. camemberti NRRL 874, NRRL 875, NRRL 66321 and P. biforme 
(P. camemberti NRRL strain 885) were grown on malt extract agar at 22°C for seven 
days. Cultures were also analyzed via LC-MS analysis.  
Samples of brie and camembert cheese bought commercially and those made in 
lab were also analyzed using the same HPLC and LC-MS detection methods outlined 
above.  The lab generated cheese samples were made with mesophilic cheese culture 
(New England Cheesemaking Supply Co., South Deerfield, MA) and P. camemberti 
NRRL 874 and P. biforme NRRL 885 individually as the ripening fungi.  Curds were 
allowed to mature for eight weeks.  
 
Results 
Penicillium camemberti has an ergot alkaloid synthesis (eas) gene cluster with a 
unique combination of eas genes 
Prior research has established that the genes dmaW, easF, easC, easE, and 
easD (Figure 3) encode the enzymes that catalyze the reactions that transform DMAPP 
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and tryptophan to chanoclavine-I aldehyde (Figure 2).  Genomes of other fungi were 
investigated for contigs that contain the eas genes through sequence queries. The 
search revealed that P. camemberti contains an eas cluster containing homologs of 
dmaW, easF, easC, easE, and easD (Figure 3;Table 2). This same observation has 
recently been noted by Martin et al. (2017). Further analysis of the P. camemberti contig 
that contained the eas gene cluster revealed a copy of the gene easH, alleles of which 
have two very different functions in two different fungi (Havemann et al., 2014; 
Jakubczyk et al., 2015) and also a copy of a novel gene with undetermined functionality, 
referred to as easQ (Figure 3;Table 2). The presence of this combination of genes 
indicated that P. camemberti has the genetic potential to produce chanoclavine-I 
aldehyde, with the possibility that the products of easH and easQ genes modify 
chanoclavine-I aldehyde into a more complex ergot alkaloid.   
Penicillium camemberti alleles of easH and easQ contribute to ergot alkaloid 
synthesis 
Roles in ergot alkaloid biosynthesis for P. camemberti genes easH and easQ 
were derived via transformation studies. The easH and easQ genes of P. camemberti 
strain NRRL 874 were individually PCR amplified and then attached to a N. fumigata 
easA/easG bidirectional promoter via fusion PCR. The easH/easQ fusion PCR product 
was co-transformed along with pBC-Phleo into a chanoclavine aldehyde accumulating 
easA ko strain of N. fumigata.  Eight fungal transformant colonies grew on 400-µg/mL 
phleomycin plates and were then analyzed by HPLC with fluorescence detection to 
observe alkaloid accumulation. While chanoclavine aldehyde was detected, no novel or 
additional alkaloids were observed in the HPLC analysis.  DNA was extracted from the 
transformants and studied via PCR to investigate the presence of the construct (Figure 
4).  A transformant that contained easH and easQ was further analyzed by LC-MS to 
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compare its metabolite profile with that of the recipient easA ko strain of N. fumigata 
(Figures 5 and 6). The transformed fungal strain was found to produce chanoclavine-I 
(Figure 5C) and a pair of analytes with m/z values of 269.1288 (Figure 6).  A pair of 
compounds with the same molecular ion and retention times was produced by 
Penicillium biforme (Figure 6), a close relative and proposed ancestor to P. camemberti 
but not by the chanoclavine aldehyde-accumulating easA ko strain of N. fumigata used 
as a recipient in this experiment (Figure 5).  Prior research has established that P. 
biforme produces of the isomeric pair of ergot alkaloids called rugulovasine A and 
rugulovasine B, the [M+H]+ for each of which has a calculated m/z of 269.1285. Further 
comparison of P. biforme and the easH/easQ-transformed easA ko strain of N. fumigata 
via fragmentation analysis revealed that the two produced identical fragments, the m/z 
values of which matched with the fragments produced upon fragmentation of 
rugulovasine (De Medeiros et al., 2015) (Figure 6). The data indicate that that the 
products of easH and easQ act on chanoclavine aldehyde to produce rugulovasines A 
and B.  
Individual functions of easH and easQ 
 While together easH and easQ were observed to produce rugulovasines from 
chanoclavine-I aldehyde, the individual functions of the products of these genes were 
also explored. P. camemberti easH gene under the control of the N. fumigata easA 
promoter was transformed into the chanoclavine-I aldehyde-accumulating easA ko 
strain of N. fumigata. Ten transformants containing the easH expression construct grew 
on media containing 400 µg/mL phleomycin, indicating that those cultures had taken up 
the phleomycin resistance-conferring construct. PCR analysis of genomic DNA template 
demonstrated that the transformant contained the introduced easH gene (Figure 7A).  
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RT-PCR analysis of cDNA template demonstrated that the easH mRNA was transcribed 
in the transformant (Figure 8A), indicating that the gene was being expressed. 
Sequence analysis and prior research indicates that both EasH and EasQ may be 
oxidases. Thus it is likely that they may be adding an oxygen to chanoclavine-I 
aldehyde. This addition would result in the m/z value observed for chanoclavine-I 
aldehyde increasing from 255 to 271. Therefore, special attention was paid in LC/MS 
analyses for appearance or increase in analytes with m/z of 271. The transformed strain 
was analyzed for accumulation of ergot alkaloids by HPLC with fluorescence detection 
and by LC-MS, but no novel peaks or ratios were observed as compared to the profile 
of the N. fumigata easA knockout. EasQ was studied in the same manner, by 
transforming the chanoclavine-I aldehyde accumulating easA ko strain of N. fumigata 
with the P. camemberti easQ gene linked with the N. fumigata easA promoter. PCR and 
RT-PCR analyses indicated the gene was present and transcribed (Figure 7B; Figure 
8B). HPLC with fluorescence detection did not reveal the presence of any novel 
metabolites when only a single gene was expressed.  However, when analyzed on LC-
MS it was observed there was a large peak at m/z in the easQ transformant. This m/z 
271 peak was also observed in the N. fumigata easA knockout and the easH 
transformant, but in very small quantities. Thus, it was hypothesized that the m/z 271 
product may be the oxidation product of the m/z 255 analyte (chanoclavine-l aldehyde) 
and that the ratios of these anayltes may differ between strains. The areas under the 
EIC peaks were then measured and analyzed using ANOVA. It was found that the ratios 
were significantly different based on the measured strain (p=0.0017). A Tukey’s multiple 
comparison test showed that the N. fumigata easA with the easQ gene had a much 
higher m/z 271 to m/z 255 ratio than the N. fumigata easA knockout strain (p=0.002) or 
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the easH transformned N.fumigata easA knockout (p=0.007), supporting the hypothesis 
that EasQ oxidized chanoclavine-I aldehyde to a molecule with m/z 271 (Figure 9; Table 
3). 
Investigation of the lack of accumulation of ergot alkaloids in P. camemberti 
strain NRRL 874 
Possible reasons for lack of accumulation of rugulovasine in P. camemberti 
include lack of expression of eas genes, misprocessing of eas gene transcripts, or null 
mutations in individual eas genes.  Whether the eas genes of P. camemberti were 
transcriptionally active was investigated in qualitative RT-PCR analyses.  Messenger 
RNA from dmaW, easF, easC, easE, easD, easH and easQ were present in reverse 
transcriptase-PCR analyses indicating that those genes are being transcribed in P. 
camemberti strain NRRL 874 when grown in malt extract broth (Figure 10).  
Additionally, sequencing results proved that the mRNAs were being processed properly, 
as the cDNA contained open reading frames corresponding to those for functional eas 
genes from N. fumigata.  
The possibility that individual eas genes of P. camemberti were mutated was 
investigated by comparing the P. camemberti eas gene cluster to the functional eas 
cluster of P. biforme.  The contig of P. biforme that contains its eas gene cluster was 
obtained from NCBI GENbank (accession number CBXO010000115.1) and compared 
to the P. camemberti eas gene cluster (GenBank accession CBVV010000119.1) by 
Blast analysis. The two eas clusters were nearly identical, with the exception of five 
differences in the coding regions of eas genes and seven intergenic differences or 
polymorphisms (Figure 11).  Each of the five polymorphisms that occurred within coding 
sequences resulted in changes in amino acids in four different enzymes (Figure 11C).  
18 
 
Two amino acid changes occurred in EasE, one in EasC, one in DmaW, and one in 
EasQ.  
In order to test functionality of the P. camemberti eas genes, three of the four 
genes that contained SNPs relative to the established functional homologs in P. biforme 
were transformed into previously constructed N. fumigata knockout strains; the function 
of EasQ was evident from its co-expression with EasH in N. fumigata strain easA ko.  
Transformation with P. camemberti dmaW and easE complemented the respective N. 
fumigata mutants.  Transformed strains that contained the dmaW or easE constructs 
each accumulated fumigaclavine C, indicating that the P. camemberti allele restored the 
N. fumigata ergot alkaloid pathway (Figure 12; Figure 7C-D).  Attempts to complement 
an easC knockout mutant of N. fumigata (Goetz et al., 2011) did not result in a strain 
that expressed easC, thus the function of the EasC enzyme could not be assessed.  
 
Analysis of potential ergot alkaloid accumulation in cheese 
 Four different wheels of Camembert cheese were cultured and ripened with P. 
biforme NRRL strain 885 and P. camemberti NRRL strain 874 for eight weeks (Figure 
13). Samples were analyzed by LC-MS along with a sample of P. biforme grown on malt 
extract agar for comparison.  Rugulovasine was not detected in any camembert cheese 
sample. Samples of commercial cheese ripened with P. camemberti also were 





My data illustrates that P. camemberti previously had the genetic capacity to 
produce ergot alkaloids such as chanoclavine-I and rugulovasines A and B.  My 
research also has identified a new ergot alkaloid biosynthesis gene (easQ), provided 
evidence for a novel functionality of an allele of the gene easH, and indicated a 
biosynthetic pathway for the rugulovasine class of ergot alkaloids.  The transformation 
of easH and easQ into the chanoclavine-I aldehyde-accumulating easA knockout strain 
of N. fumigata induced the fungus to produce the alkaloids rugulovasines A and B. The 
biochemical activity and sequence in which easH and easQ functioned were also 
studied. Typically, the eas genes present in N. fumigata control the reactions to turn 
tryptophan and dimethylallylpyrophosphate to chanoclavine-I aldehyde and then to 
festuclavine and fumigaclavine A, B, and C (Figure 2) (Robinson and Panaccione, 
2015). While it is clear from the expression studies in N. fumigata that the easH and 
easQ genes of P. camemberti are functional, P. camemberti does not produce ergot 
alkaloids in culture nor were the alkaloids detected in any cheese samples obtained or 
created. To explain this lack of ergot alkaloids in P. camemberti in light of the genetic 
data, we looked at evolutionary data, taking into account the closely related 
rugulovasine-producing strains of Penicillium spp.  Differences in the eas gene clusters 
between P. camemberti and P. biforme were studied through complementation and 
mRNA expression studies to investigate a possible explanation.  It was found that P. 
camemberti encodes functional easE and dmaW genes but further investigation of the 
easC gene is needed to fully understand if all the genes in the ergot alkaloid synthesis 




Structurally, rugulovasines are classified as indole alkaloids in the ergot family 
that contain a spirocyclic butyrolactone subunit (Zhang et al., 2013). Rugulovasines are 
unique as they occur as two racemic isomers, A and B, that are capable of being 
interconverted by heating in polar solvents (Meurant, 2012). Ergot alkaloids are great 
chemical structures to undergo biohalogenation as they contain nitrogen in their 
chemical structure (Gribble, 2008). Thus, it there are also naturally-occurring chlorinated 
and brominated forms of rugulovasine (De Medeiros et al., 2015).   
While the health effects of the rugulovasines are largely understudied, a few 
studies indicate they may induce negative heath consequences. Previous research 
showed that ingestion of rugulovasines by day-old poultry caused acute toxicity effects 
(Dorner et al., 1980). In fact, this toxicity was used as a bioassay to purify the 
rugulovasines.  It has also been reported that the rugulovasines caused decreased 
blood pressure when administered to cats (Meurant, 2012).  Our LC-MS data indicate 
that P. biforme and the easH/easQ-transformed easA ko strain of N. fumigata are 
capable of producing both rugulovasine A and B (Figure 6). This is evident as the 
fragmentation spectra for both rugulovasine A and B match the fragmentation spectra of 
rugulovasines from previous studies (De Medeiros et al., 2015).  However, the 
chlorinated and brominated forms of rugulovasine were not detected when analyzed on 
LC-MS based on the absence of analytes of the predicted masses established in 
analyses by De Medeiros et al. (2015).  It is also pertinent to note that while 
rugulovasines were detected in large quantities in our LC-MS data, they were not 
detected on the HPLC with fluorescence detection (monitoring at excitation/emission 
wavelengths of 272 nm/372 nm or 310 nm/410 nm, respectively). Future steps may be 
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to monitor different combinations of excitation and emission wavelengths in order for the 
rugulovasines to fluoresce for detection on the HPLC. It is also possible that the 
particular structure of these compounds prevents or quenches fluorescence.  
Proposed mechanism of rugulovasine biosynthesis 
We hypothesize that EasQ, predicted by sequence analysis to be an aldehyde 
dehydrogenase, oxidizes chanoclavine-I aldehyde to the corresponding carboxylic acid 
(Figure 14). As the name indicates, an aldehyde dehydrogenase is capable of acting on 
aldehydes, oxidizing the aldehyde to a carboxylic acid. The aldehyde dehydrogenase 
family of enzymes are NADP-dependent that share the basic structural and functional 
attributes that allow them to catalyze the oxidation of a number of different aliphatic and 
aromatic aldehydes (Lindahl, 1992). Evidence that the P. camemberti easQ gene is 
similar yet different from the other forms of aldehyde dehydrogenases can be observed 
from the phylogenetic and sequence match data (Figure 14B). In fact, a close homolog 
of easQ with two introns in identical position and phase is found in the P. camemberti 
genome and has close homologs in several other members of the Trichocomaceae, 
including N. fumigata.  The data favor that easQ acts as the nomenclature indicates, 
turning chanoclavine-I aldehyde into chanoclavine-I acid (Figure 15). Analysis of the 
transformed chanoclavine-I aldehyde accumulating easA knockout strain of N. fumigata 
with the easQ gene on LC-MS supports this proposed mechanism as copious amounts 
of an analyte with the mass of [chanoclavine-l acid + H]+ (m/z 271) was detected (Figure 
9). Whereas small quantities of this same metabolite were observed in the N. fumigata 
easA knockout strain, the ratio of chanoclavine-I (resumed substrate) to the m/z 271 
analyte (presumed product) increased significantly upon expression of easQ.  These 
results supported the hypothesis that EasQ may be acting on chanoclavine-l aldehyde 
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and converting it to the corresponding carboxylic acid. The amounts of the m/z 271 
analyte compared to chanoclavine-I were also compared to the levels of these analytes 
found in the easA knockout strain of N. fumigata with the easH gene as well as the 
chanoclavine-I aldehyde accumulating easA knockout strain of N. fumigata (Figure 9). 
While there were trace amounts of the presumed chanoclavine-l acid found in the 
chanoclavine-I aldehyde accumulating easA knockout strain of N. fumigata, the 
increase in the analyte of this mass in the easQ-transformed strain as well as the ratios 
between the aldehyde and the proposed acid are indicative of the actions of EasQ 
(Figure 15). Furthermore, Blastp search has indicated that there is a distant easQ 
homologue present in N. fumigata as well as in P. camemberti.  The other P. 
camemberti homologue, which is 58% identical in amino acid sequence to the product 
of the easQ gene used in this study, may be the parent gene from which easQ was 
neofunctionalized (Figure 14 A,B).  Thus, the product of this gene in N. fumigata may be 
responsible for the small background quantities of the analyte with the mass of 
chanoclavine-I acid in N. fumigata.  However, the data strongly favors that the P. 
camemberti EasQ is capable of converting chanoclavine-l aldehyde to chanoclavine-l 
acid (Figure 9).  
EasH, a predicted dioxygenase, would oxidize the aromatic carbon customarily 
labeled as carbon 10 in chanoclavine-I aldehyde or perhaps that same carbon in the 
corresponding carboxylic acid, chanoclavine-I acid.  Dehydration of the 10-hydroxylated 
chanoclavine-I acid would result in the formation of rugulovasine A (Figure 15).  The 
literature supports that this proposed mechanism is possible but novel, as the product of 
no other form of the easH gene has acted on this proposed substrate. Jakubczyk et al. 
(2015) proposed three mechanisms by which EasH of the fungus Aspergillus japonicus 
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might oxidize the very same carbon in a slightly different ergot alkaloid precursor to 
result in formation of cycloclavine. That study outlined three potential mechanisms that 
may be encoded for by the easH gene (Figure 16). The first two outlined mechanisms 
propose that EasH may be abstractring a hydride ion (Figure 16A), or abstracting a 
hydrogen ion from its substrate (Figure 16B). Figure 16C shows that EasH may be 
hydroxylating or halogenating its substrate. Hydroxylation is the mechanism that is 
consistent with our hypothesis for P. camemberti EasH, as it would explain 
hydroxylating the chanoclavine-I acid produced from the actions of easQ   
A study with another allele of easH from Claviceps purpurea stated that easH 
has the ability to code for enzymes that can hydroxlate amino acids that are in the first 
position of ergopeptines. The study also found that the product of that particular allele of 
easH was capable of cyclolizying the ergopeptine classes that are naturally occurring 
(Havemann et al., 2014). Figure 13C and D illustrates the phylogenetic relationships 
between the easH alleles from these fungi as well as those other fungi that share a 
similar easH gene with P. camemberti. The phylogenetic clustering of P. camemberti 
easH with those involved in cycloclavine biosynthesis support the hypothesis that they 
have similar activities on a similar substrate. 
 If EasH were to act on chanoclavine-l aldehyde (as opposed to it acid derivative 
described above), we propose that the intermediate would essentially be chanoclavine-I 
aldehyde with an additional oxygen at carbon 10, thus making its m/z around 271.  
While the easH gene alone was successfully transformed into the chanoclavine-I 
aldehyde-accumulating easA knockout strain of N. fumigata (Figure 6B), when analyzed 
on LC-MS there were no notable traces of this proposed intermediate. It is possible that 
EasQ needs to act on chanoclavine-I aldehyde first before EasH can undertake its 
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oxidation mechanisms (Figure 15).  It may also be that intermediate is unstable in this 
form and therefore does not stay in solution long enough to be detected. The fact that 
the production of rugulovasine was detected when both easH and easQ were 
expressed supports the notion that they work together in catalyzing chanoclavine-I 
aldehyde into rugulovasine.  
Ancestral species of P.camemberti are rugulovasine producers  
Phylogenetic analysis shows that P. biforme, P. fuscoglaucum and P. commune 
are perhaps the ancestral strains of P. camemberti (Ropars et al., 2015; Polonelli et al., 
1987).  P. biforme, P. fuscoglaucum and P. commune are known as common 
contaminants of cheese and other food products. The close phylogenetic relationship 
between P. biforme, P. fuscoglaucum and P. camemberti was confirmed by using 17 
different microsatellite markers (Giraud et al., 2009). P. biforme and P. commune are 
known for producing rugulovasines (Kozlovsky,1999). 
There are two chemotypes of P. commune, with Chemotype I being associated 
as a producer of cyclopenoxoic acid and rugulovasine and chemotype II producing 
fumigoclavines. P. camemberti is thought to have descended from P. commune 
chemotype I or the one that is known for producing rugulovasines (Frisvad and 
Filtenborg, 1989). This hypothesis is supported by data from Polonelli et al. (1987) who 
analyzed what appeared to be a P. camemberti mutant that produced the same 
alkaloids as P. commune. It was determined that this “mutant” was actually in a P. 
commune, thus P. commune must be the ancestor of P. camemberti (Polonelli et al., 
1987).  All of these phylogenic lineages favor the notion that the ancestor to P. 
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camemberti had the genetic capacity to produce rugulovasine but at some point in the 
domestication of the commercial strain the fungus lost that ability.  
Lack of ergot alkaloid production in P. camemberti  
While the data suggest that the products of the P. camemberti easH and easQ 
genes act on chanoclavine-l aldehyde to produce rugulovasines, ergot alkaloids were 
not detected in any strain of P. camemberti.  Interestingly enough, P. camemberti does 
transcribe all of the eas genes in the ergot alkaloid synthesis gene cluster under the 
cultural conditions commonly used in our analyses (Figure 9), which involved culturing 
the fungus in malt extract medium without agitation at ambient temperature.  Sequence 
data collected on these transcripts indicated proper processing of mRNAs, eliminating 
that step as a reason for the lack of ergot alkaloids in P. camemberti.  P. biforme shares 
a similar ergot alkaloid gene cluster with P. camemberti with the exception of a few 
nucleotide differences (Figure 11). Because there were minor differences between the 
P. camemberti easC, easE and dmaW genes in comparison to the P. biforme eas 
genes, these genes were selected for complementation studies. The P. camemberti 
dmaW and easE genes were found to be fully functional, as they were able to be 
transformed into the N. fumigata the respective knockout strain and restore the fungus’s 
ability to produce festuclavine C (Figure 12).  However, attempts to express the P. 
camemberti easC failed to result in accumulation of easC mRNA.  One potential reason 
for this observation is that expression of P. camemberti easC in N. fumigata may require 
placing the coding sequences of the gene under the control of an N. fumigata promoter.   
Implications 
The collected data has shown an ancestral capacity of P. camemberti to produce 
ergot alkaloids. The data suggested potential mechanisms of the novel P. camemberti  
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easQ gene and the novel allele of easH and the role they play in the production of 
rugulovasines. Moreover, while it may be reassuring to know that domesticated strains 
of P. camemberti used for the production of camembert-type cheeses did not produce 
any detectable ergot alkaloids, some Penicillium strain associated with dairy products 
may have the ability to produce rugulovasines (Polonelli et al., 1987). While there is little 
known about how rugulovasines may affect human health, the literature does indicate 
that it is a compound that may have detrimental heath impacts if prolonged exposure 
persists (Dorner et al., 1980; Meurant, 2012).   
It is possible that P. biforme may produce rugulovasines as a means of defense 
of resources and that P. camemberti does not need this defense as it is only found on 
cheese products which have a defined microflora and are cultivated hygienically. 
Another theory is that historically the rugulovasines may have made consumers of the 
cheese sick, therefore strains of P. camemberti that were unable to produce these 
alkaloids were selected. It is possible that there may be more to this observation and 
therefore it should be further studied.  Future studies to try to explain this phenomenon 
would include sequencing and comparing the eas gene cluster of P. fuscoglaucum and 
P. commune to try to pinpoint where this divergence may have occurred. Also, it is 
pertinent to note that while P. biforme produces rugulovasines in culture, no alkaloids 










Figure 1: Chemical structures of neurotransmitters dopamine, serotonin and 
norepinephrine on the left. These neurotransmitters interact with neuroreceptors to 
elicit a neuronal response in the body. Chemical structures of ergot alkaloids 
chanoclavine-l aldehyde and rugulovasine A are pictured on the right. Ergot alkaloids 
have a similar chemical backbone as the neurotransmitters, thus they can interact with 













Figure 2: Series of reactions catalyzed by the eas genes converting tryptophan and N-methyl DMAT to 
chanoclavine-l aldehyde. This pathway is common to most ergot alkaloid producers, with chanoclavine-I 







































Figure 3:  A: The ergot alkaloid synthesis gene cluster from P. camemberti. Genes easC, 
easF, easE, dmaW, and easD are also found in N. fumigata. The combination of easH and 
easQ are novel to P. camemberti and P. biforme. B: Ergot alkaloid gene cluster found in P. 
biforme. C: gene cluster found in N. fumigata. While the eas gene cluster is more extensive 
















Table 1: Primer combinations, annealing temperature, and extension time for the various 

















Gene % Identity Species Function Accession number 
easQ 97% Aspergillus flavus aldehyde dehydrogenase XP_002376976.1
easH 99% Byssochlamys spectabilis Phytanoyl-CoA dioxygenase GAD93023.1
easC 86% Penicillium roqueforti Catalase haem-binding site CDM36675.1




easE 94% Penicillium roqueforti Berberine/berberine-like CDM36677.1
dmaW 93% Penicillium roqueforti Tryptophan 
dimethylallyltransferase
CDM36678.1
easD 99% Aspergillus lentulus chanoclavine-I 
dehydrogenase
GAQ03955.1
Table 2: Ergot alkaloid synthesis genes found in P. camemberti and their similarity to genes found 
in other known alkaloid producing fungi. The P. camemberti genome was obtained through NCBI 
and the individual genes were compared through NCBI Blastx. The function of these genes and 




















Figure 4: P. camemberti easH and easQ were both present in the 
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Figure 5. Extracted ion chromatogram m/z 269.2 from mass spectrometry analysis of N. 
fumigata easA ko (A), the N. fumigata easA knockout transformed with easH and easQ (B), 







































Figure 6: Mass spectrometry fragmentation patterns of rugulovasine (De Medeiros et. al., 





















Figure 7: PCR evidence illustrating that fungal transformations were 
successful. Primer sets for specific amplification of the genes were used in 
conjunction with the transformed N. fumigata strains. A) presence of easH in 
the N. fumigata easA ko strain. B) presence of easQ in the N. fumigata easA ko 
strain. C) presence of dmaW in the N. fumigata dmaW ko strain. D) presence of 
































Figure 8: cDNA of the easH/easQ transformed N. fumigata easA knockout. A) shows 
presence of easH while B) shows easQ.  Primers for easQ flanked an intron, and the size 



















Figure 9:  271.1/255.1 m/z ratio differences observed in the LC-MS data of N. fumigata 
easA ko, N. fumigata easA ko+easH and N. fumigata easA ko+easQ.  Brown-Forsythe 
analysis indicates significant differences between A and B as indicated by p-value 








Ratio of Analytes at m/z 271.1 vs. m/z 255.1
N. fumigata easA ko N. fumigata easA ko+easH N. fumigata easA ko+easQ



































Strains analyzed by LC-MS p-Value
N. fumigata easA ko+ easQ vs. N. fumigata easA ko 0.002*
N. fumigata easA ko+ easQ vs. N. fumigata easA ko+ easH 0.007*
N. fumigata easA ko+ N. fumigata easA ko +easH 0.673
Table 3: Calculated p-values by Brown-Forsythe analysis that show that there is a 
difference in ratio of  271.1/255.1 m/z  based on the strains analyzed. Asterisks 











Figure 10: RT-PCR of dmaW, easF, easC , easE, easD,easH and easQ transcripts from 
P. camemberti NRRL strain 874 cDNA. All seven genes in the ergot alkaloid gene cluster 













Figure 11: A) Mutation sites of the P. camemberti eas gene cluster in comparison to P. 
biforme  as indicated with stars. Black stars indicate the mutations of the non coding region 
and are outlined in B), white stars indicate the mutations within the coding regions and are 
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Transformant Sample Amount of 
Fumigaclavine C (ng/mL)
easE --------- 1035
dmaW  --------- 1038
N. fumigata WT   --------- 3106
Figure 12: HPLC of the P. camemeberti easE (blue) and dmaW (red) N.fumigata knockout 
transformants in comparison to wild type N. fumigata (black).  This analysis indicates that the 
two transformants are producing fumigaclavine C (58.7), just in smaller quantities than the wild 
type N. fumigata. EasE transformant also appears to less efficient at converting festuclavine to 










Figure 13: Camembert cheese prepared with P. camemberi NRRL 874 and P. biforme NRRL 







Figure 14: Phylogenetic analysis of the easQ and easH genes from P. camemberti and their 
relationship to those of other fungi.   A Phylogenetic relationship between the top NCBI blastp matches 
of the P. camemberti easQ gene. It is notable that there is a paralog of the P. camemberti and P. 
biforme easQ gene. B The numerical relationships between homologues of easQ from other fungi with 
easQ of P. camemberti. C Phylogenetic relationship of P. camemberti easH and homologues from other 
fungi.  D Homologues of P. camemberti easH based on NCBI blastp search. It is interesting to note the 






























Figure 15: Proposed synthesis of rugulovasine from chanoclavine-l aldehyde.  EasQ, predicted 
by sequence analysis to be an aldehyde dehydrogenase, would oxidize the aldehyde to an acid.  
EasH, a predicted dioxygenase, would oxidize the aromatic carbon.  Dehydration would result in 










Figure 16: Proposed mechanisms of EasH activity as described by Jakubczyk et al. (2015) in 
the fungus Aspergillus japonicus. A EasH may be abstractring a hydride ion, B EasH may be 
abstracting a hydrogen ion from its substrate. C  EasH  may be hydroxylating or halogenating its 
substrate. Hydroxylation is the mechanism that is consistent with our hypothesis for P. 
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